StockTipsArenaBeta

BUY Mankind Pharma Limited — Mehul Kothari, Anand Rathi

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byMehul Kothari, Anand RathiHorizon: NA (inferred Swing (≤2wk))3 Jun 2026via Zee Business (Live)

Entry₹2,355Stated
Target₹2,460
Total upside +4.46% (call closed)
Stop loss₹2,280-3.18% risk
At expiry₹2,359.216 Jun 2026, 3:30 pm
Expired+0.18%
Follow Mehul Kothari for new calls(23% target hit, 100 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 150 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:33 pm IST
2 supporting0 opposing
Supports the BUY call (2)

Mankind Pharma Limited, through its subsidiary, acquired the remaining 10% stake in Upakarma Ayurveda Private Limited, making Upakarma a wholly-owned subsidiary. This acquisition aims to improve opera

NSE · Acquisition·2 Jun · 2w ago

(opens in new tab)

Mankind Pharma Ltd has informed about a stake acquisition by one of its wholly-owned subsidiary companies.

BSE · Company Update·2 Jun · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Mehul Kothari, Anand Rathi

Every call and its outcome